These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8725044)

  • 41. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen].
    Morote Robles J; López López M; Encabo Duro G; de Torres Ramírez I
    Actas Urol Esp; 1999 May; 23(5):400-5. PubMed ID: 10427813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
    Zhang W; Zheng X; Wang Y; Xiao H
    Urology; 2016 Nov; 97():212-218. PubMed ID: 27327576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicted and actual change in serum PSA following prostatectomy for BPH.
    Lloyd SN; Collins GN; McKelvie GB; Hehir M; Rogers AC
    Urology; 1994 Apr; 43(4):472-9. PubMed ID: 7512298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME; Mazo EB; Chekhonin VP
    Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic alterations in benign prostatic hyperplasia patients.
    Mohamed HM; Aly MS; Hussein TD
    Ger Med Sci; 2017; 15():Doc16. PubMed ID: 29234244
    [No Abstract]   [Full Text] [Related]  

  • 49. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
    Canto EI; Singh H; Shariat SF; Lamb DJ; Mikolajczyk SD; Linton HJ; Rittenhouse HG; Kadmon D; Miles BJ; Slawin KM
    Urology; 2004 May; 63(5):905-10; discussion 910-1. PubMed ID: 15134977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between serum PSA and prostate volume in benign hyperplasia].
    Ojea Calvo A; Rodrigo AA; Verez Vivero MM; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Nogueira March JL
    Actas Urol Esp; 1994 Mar; 18(3):178-80. PubMed ID: 7518640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
    Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of prostate-specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia.
    Masuda H; Kawakami S; Sakura M; Fujii Y; Koga F; Saito K; Numao N; Yonese J; Fukui I; Kihara K
    Int J Urol; 2012 Oct; 19(10):929-35. PubMed ID: 22694207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of patients with diseases of the prostate using prostate-specific antigen density.
    Wolff JM; Boeckmann W; Effert PJ; Handt S; Jakse G
    Br J Urol; 1995 Jul; 76(1):41-6. PubMed ID: 7544203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
    Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
    Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between serum prostate-specific antigen and calculated epithelial volume.
    Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
    Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.